{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:57:54Z","timestamp":1792691874308,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.ajo.2021.02.022","type":"journal-article","created":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T15:27:46Z","timestamp":1614007666000},"page":"25-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Incidence, Risk Factors and Complications of Ocular Graft-Versus-Host Disease Following Hematopoietic Stem Cell Transplantation"],"prefix":"10.1016","volume":"227","author":[{"given":"Marco","family":"Pellegrini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Bernabei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Barbato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Arpinati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2617-0289","authenticated-orcid":false,"given":"Giuseppe","family":"Giannaccare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piera","family":"Versura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Bonifazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ajo.2021.02.022_bib0001","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/bmt.2015.6","article-title":"Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015","volume":"50","author":"Sureda","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.ajo.2021.02.022_bib0002","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1182\/blood.V100.2.406","article-title":"Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse","volume":"100","author":"Lee","year":"2002","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ajo.2021.02.022_bib0003","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1182\/blood-2014-01-514752","article-title":"Current issues in chronic graft-versus-host disease","volume":"124","author":"Soci\u00e9","year":"2014","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.ajo.2021.02.022_bib0004","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","article-title":"Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients","volume":"69","author":"Shulman","year":"1980","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.ajo.2021.02.022_bib0005","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.ajo.2021.02.022_bib0006","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1182\/blood-2016-07-686642","article-title":"Classification systems for chronic graft-versus-host disease","volume":"129","author":"Lee","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ajo.2021.02.022_bib0007","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0161-6420(83)34604-2","article-title":"Ocular manifestations of graft-vs-host disease","volume":"90","author":"Franklin","year":"1983","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.ajo.2021.02.022_bib0008","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/bmt.2012.56","article-title":"Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteria","volume":"47","author":"Jacobs","year":"2012","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.ajo.2021.02.022_bib0009","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.survophthal.2012.08.004","article-title":"Ocular graft-versus-host disease: a review","volume":"58","author":"Shikari","year":"2013","journal-title":"Surv Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2021.02.022_bib0010","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00417-019-04301-6","article-title":"Ocular surface system alterations in ocular graft-versus-host disease: all the pieces of the complex puzzle","volume":"257","author":"Giannaccare","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2021.02.022_bib0011","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/bmt.2015.187","article-title":"Incidence and risk factors for ocular GVHD after allogeneic hematopoietic stem cell transplantation","volume":"50","author":"Na","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"10.1016\/j.ajo.2021.02.022_bib0012","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1136\/bjophthalmol-2014-306438","article-title":"Risk factors for the development of ocular graft-versus-host disease (GVHD) dry eye syndrome in patients with chronic GVHD","volume":"99","author":"Wang","year":"2015","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2021.02.022_bib0013","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.ajo.2021.02.022_bib0014","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archopht.118.5.615","article-title":"Reliability and validity of the Ocular Surface Disease Index","volume":"118","author":"Schiffman","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2021.02.022_bib0015","unstructured":"NEI\/Industry Grading System. American Academy of Ophthalmology, 2014. Available at: https:\/\/www.aao.org\/image\/neiindustry-grading-system. Accessed November 1, 2020."},{"issue":"3","key":"10.1016\/j.ajo.2021.02.022_bib0016","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","article-title":"TFOS DEWS II diagnostic methodology report","volume":"15","author":"Wolffsohn","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ajo.2021.02.022_bib0017","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1038\/srep03419","article-title":"International chronic ocular graft-versus-host disease (GVHD) consensus group: proposed diagnostic criteria for chronic GVHD (Part I)","volume":"3","author":"Ogawa","year":"2013","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.ajo.2021.02.022_bib0018","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/sj.bmt.1705727","article-title":"Competing risk analysis using R: an easy guide for clinicians","volume":"40","author":"Scrucca","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.ajo.2021.02.022_bib0019","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/sj.bmt.1701423","article-title":"Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis","volume":"22","author":"Carlens","year":"1998","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.ajo.2021.02.022_bib0020","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1182\/blood-2005-04-1614","article-title":"Influence of T-cell depletion on chronic graft-versus-host disease: results of a multicenter randomized trial in unrelated marrow donor transplantation","volume":"106","author":"Pavletic","year":"2005","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.ajo.2021.02.022_bib0021","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1365-2141.2007.06543.x","article-title":"Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program","volume":"137","author":"Ozawa","year":"2007","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.ajo.2021.02.022_bib0022","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1182\/blood-2010-08-302109","article-title":"Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria","volume":"117","author":"Flowers","year":"2011","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.ajo.2021.02.022_bib0023","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJMoa1203517","article-title":"Peripheral-blood stem cells versus bone marrow from unrelated donors","volume":"367","author":"Anasetti","year":"2012","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ajo.2021.02.022_bib0024","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1542-0124(12)70207-0","article-title":"Chronic ocular surface disease after allogeneic bone marrow transplantation","volume":"3","author":"Balaram","year":"2005","journal-title":"Ocul Surf"},{"issue":"7","key":"10.1016\/j.ajo.2021.02.022_bib0025","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1097\/ICO.0b013e3181ca321c","article-title":"Ocular graft-versus-host disease after allogeneic stem cell transplantation","volume":"29","author":"Westeneng","year":"2010","journal-title":"Cornea"},{"issue":"5","key":"10.1016\/j.ajo.2021.02.022_bib0026","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1097\/ICO.0b013e318276bc56","article-title":"Prevalence of dry eye syndrome after allogeneic hematopoietic stem cell transplantation","volume":"32","author":"Ivanir","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.ajo.2021.02.022_bib0027","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/ICO.0000000000000340","article-title":"Onset of ocular graft-versus-host disease symptoms after allogeneic hematopoietic stem cell transplantation","volume":"34","author":"Shikari","year":"2015","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.ajo.2021.02.022_bib0028","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jtos.2018.04.001","article-title":"Ocular chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation in an Italian referral center","volume":"16","author":"Berchicci","year":"2018","journal-title":"Ocul Surf"},{"issue":"9","key":"10.1016\/j.ajo.2021.02.022_bib0029","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.ophtha.2009.04.054","article-title":"Ocular findings after allogeneic hematopoietic stem cell transplantation","volume":"116","author":"Tabbara","year":"2009","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2021.02.022_bib0030","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41409-020-0993-3","article-title":"Chronic ocular graft-versus-host disease after allogeneic haematopoietic stem cell transplantation in Denmark\u2014factors associated with risks and rates in adults according to conditioning regimen","volume":"56","author":"Jeppesen","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.ajo.2021.02.022_bib0031","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3109\/02713683.2014.966847","article-title":"Sex-steroid imbalance in females and dry eye","volume":"40","author":"Versura","year":"2015","journal-title":"Curr Eye Res"},{"issue":"4","key":"10.1016\/j.ajo.2021.02.022_bib0032","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1470-2045(09)70352-3","article-title":"Long-term outcome and late effects in patients transplanted with mobilised blood or bone marrow: a randomised trial","volume":"11","author":"Friedrichs","year":"2010","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.ajo.2021.02.022_bib0033","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/j.bbmt.2016.06.020","article-title":"Risk factors and outcome of chronic graft-versus-host disease after allogeneic stem cell transplantation-results from a single-center observational study","volume":"22","author":"Grube","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.ajo.2021.02.022_bib0034","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jtos.2020.03.008","article-title":"The impact of anticancer drugs on the ocular surface","volume":"18","author":"Chiang","year":"2020","journal-title":"Ocul Surf"},{"issue":"7","key":"10.1016\/j.ajo.2021.02.022_bib0035","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/bmt.2015.72","article-title":"Meibography and meibomian gland measurements in ocular graft-versus-host disease","volume":"50","author":"Engel","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.ajo.2021.02.022_bib0036","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/ICO.0000000000000747","article-title":"P. Dry eye disease is already present in hematological patients before hematopoietic stem cell transplantation","volume":"35","author":"Giannaccare","year":"2016","journal-title":"Cornea"},{"issue":"10","key":"10.1016\/j.ajo.2021.02.022_bib0037","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1097\/ICO.0000000000001585","article-title":"Meibomian gland dropout in hematological patients before hematopoietic stem cell transplantation","volume":"37","author":"Giannaccare","year":"2018","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.ajo.2021.02.022_bib0038","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/jamaophthalmol.2015.5322","article-title":"Geographic variation in the rate and timing of cataract surgery among US communities","volume":"134","author":"Kauh","year":"2016","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2021.02.022_bib0039","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/ICO.0000000000000395","article-title":"Outcomes of cataract surgery in graft-versus-host disease","volume":"34","author":"de Melo Franco","year":"2015","journal-title":"Cornea"},{"key":"10.1016\/j.ajo.2021.02.022_bib0040","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.2147\/OPTH.S51180","article-title":"Bilateral corneal ulceration in ocular graft-versus-host disease","volume":"7","author":"Stevenson","year":"2013","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ajo.2021.02.022_bib0041","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ajo.2016.12.026","article-title":"Elevated neutrophil elastase in tears of ocular graft-versus-host disease patients","volume":"176","author":"Arafat","year":"2017","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2021.02.022_bib0042","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.survophthal.2016.12.010","article-title":"Management of high-risk corneal transplantation","volume":"62","author":"Di Zazzo","year":"2017","journal-title":"Surv Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2021.02.022_bib0043","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/01676830.2016.1193539","article-title":"Conjunctival cicatrizing disease presenting with lacrimal obstruction","volume":"35","author":"Satchi","year":"2016","journal-title":"Orbit"},{"issue":"5","key":"10.1016\/j.ajo.2021.02.022_bib0044","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/s41409-018-0339-6","article-title":"Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT","volume":"54","author":"Inamoto","year":"2019","journal-title":"Bone Marrow Transplant"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939421000878?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939421000878?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:45:50Z","timestamp":1757598350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939421000878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":44,"alternative-id":["S0002939421000878"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2021.02.022","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence, Risk Factors and Complications of Ocular Graft-Versus-Host Disease Following Hematopoietic Stem Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2021.02.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}